Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD38: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD38 is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, regulates. Associated with ALS, Aging, Als. Connected to 290 entities in the SciDEX knowledge graph.
| Gene Symbol | CD38 |
| Chromosome | 4p15.32 |
| Protein Type | Enzyme |
| Target Class | Enzyme |
| Function | cADPR acts as a potent second messenger that releases calcium from intracellular stores (endoplasmic reticulum) through ryanodine receptors[@guse2005]. |
| Mechanism of Action | Monoclonal antibody targeting or small molecule inhibitor of NAD+ consuming activity |
| Primary Expression | various tissues including brain cells (neurons, astrocytes, microglia) and plays important roles in neuro |
| Druggability | Medium (0.61) |
| Clinical Stage | Approved |
| Amino Acids | 301 aa |
| Pathways | Cerebrovascular, Circadian Rhythm, Differentiation, Immune Response, Mitochondrial Function |
| UniProt ID | H0Y950 |
| Ensembl ID | ENSG00000104419 |
| GeneCards | CD38 |
| Human Protein Atlas | CD38 |
| Associated Diseases | ALS, ALZHEIMER, Aging, Alzheimer's disease |
| Known Drugs/Compounds | NICOTINAMIDE, nicotinamide |
| Interactions | NAMPT, PARP1, EGR2, SIRT6, STAT3, SIRT1 |
| SciDEX Target | View Target Profile (8 clinical trials) |
| KG Connections | 572 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CD38["CD38"] -->|"associated"| neurodegeneration["neurodegeneration"]
CD38["CD38"] -->|"interacts"| NAMPT["NAMPT"]
CD38["CD38"] -->|"co discussed"| C1Q["C1Q"]
CD38["CD38"] -->|"co discussed"| NAMPT_1["NAMPT"]
CD38["CD38"] -->|"co discussed"| GPX4["GPX4"]
CD38["CD38"] -->|"co discussed"| PLA2G6["PLA2G6"]
NAMPT_2["NAMPT"] -->|"interacts"| CD38["CD38"]
MMP9["MMP9"] -->|"co discussed"| CD38["CD38"]
SLC7A11["SLC7A11"] -->|"co discussed"| CD38["CD38"]
AQP4["AQP4"] -->|"co discussed"| CD38["CD38"]
style CD38 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Lysosomal Cholesterol Efflux | promotes | process | 0.95 |
| Neurons | expressed_in | cell_type | 0.90 |
| Microglial Cells | expressed_in | cell_type | 0.90 |
| Lysosomal Cholesterol Efflux | associated_with | process | 0.90 |
| Astrocytes | expressed_in | cell_type | 0.90 |
| Nad | regulates | compound | 0.85 |
| Nad | catalyzes | compound | 0.85 |
| ADENOSINERGIC PATHWAY | involved_in | entity | 0.85 |
| purinergic signaling | regulates | pathway | 0.85 |
| mitochondrial transfer | mediates | process | 0.85 |
| mitochondrial transfer | associated_with | process | 0.85 |
| Mitochondrial Transfer | mediates | mechanism | 0.85 |
| Immune Response | involved_in | process | 0.85 |
| Neurodegeneration | involved_in | process | 0.85 |
| Neuroinflammation | involved_in | process | 0.85 |
| NAD metabolism | involved_in | pathway | 0.80 |
| NAMPT | co_mentioned_with | gene | 0.80 |
| programmed cell death | inhibits | process | 0.80 |
| Neurodegeneration | contributes_to | disease | 0.80 |
| ubiquitin-proteasome | participates_in | pathway | 0.80 |
| APOPTOSIS | suppresses | process | 0.80 |
| NAD+ metabolism | regulates | pathway | 0.80 |
| ATP production | regulates | process | 0.75 |
| MIRO1 | interacts_with | gene | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Aging | inhibits | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| SIRT1 | activates | gene | 0.70 |
| Parkinson's disease | protects_against | disease | 0.70 |
| Immune Response | regulates | pathway | 0.70 |
| unfolded protein response | participates_in | pathway | 0.70 |
| NAD | implicated_in | gene | 0.70 |
| macrophages | activates | cell_type | 0.70 |
| neural stem cells | expressed_in | cell_type | 0.70 |
| stem cells | expressed_in | cell_type | 0.70 |
| PARP1 | reduces | gene | 0.65 |
| SIRT6 | reduces | gene | 0.65 |
| Als | associated_with | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Longevity | associated_with | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GJ-PD | upregulates | drug | 0.90 |
| h-cb833ed8 | targets_gene | hypothesis | 0.90 |
| h-cb833ed8 | targets | hypothesis | 0.80 |
| SDA-2026-04-01-gap-013 | targets | analysis | 0.80 |
| GJ-PD herbal pair | upregulates | drug | 0.80 |
| Geum japonicum Thunb. var. chinense-Potentilla decorata H. Andres | upregulates | drug | 0.80 |
| Aging | upregulates | process | 0.80 |
| CANCER | associated_with | gene | 0.70 |
| NAD | inhibits | gene | 0.70 |
| NAD | activates | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| NAMPT | interacts_with | gene | 0.64 |
| ADORA2B | associated_with | gene | 0.60 |
| P2RY12 | associated_with | gene | 0.60 |
| P2RX1 | associated_with | gene | 0.60 |
| P2RX4 | associated_with | gene | 0.60 |
| P2RX7 | associated_with | gene | 0.60 |
| NAMPT | inhibits | gene | 0.60 |
| SIRT6 | inhibits | gene | 0.60 |
| EGR2 | activates | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| P2RY1 | associated_with | gene | 0.60 |
| PANX1 | associated_with | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| SIRT1 | regulates | gene | 0.60 |
| NAMPT | associated_with | gene | 0.60 |
| TFEB | activates | gene | 0.60 |
| LRRK2 | regulates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| SLAMF7 | therapeutic_target | gene | 0.60 |
| CCR1 | regulates | gene | 0.60 |
| MRC1 | regulates | gene | 0.60 |
| C1QB | regulates | gene | 0.60 |
| CXCL12 | expressed_in | gene | 0.60 |
| SRC | expressed_in | gene | 0.60 |
| KIF5B | regulates | gene | 0.60 |
| RORA | associated_with | gene | 0.60 |
| BMP7 | associated_with | gene | 0.60 |
| CX3CR1 | associated_with | gene | 0.60 |
| AHR | associated_with | gene | 0.60 |
| EP300 | associated_with | gene | 0.60 |
| JUN | associated_with | gene | 0.60 |
| JAK2 | associated_with | gene | 0.60 |
| CCL20 | associated_with | gene | 0.60 |
| P2RX5 | associated_with | gene | 0.60 |
| BAX | treats | gene | 0.60 |
| NLRP3 | inhibits | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| CXCR4 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.570
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.703
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||